Phase 2 trial of the continuous IV administration of interferon-beta in patients with disseminated malignant melanoma.

Skinmed

Volumn 5, Issue 6, 2006, Pages 271-276

  Voelter Mahlknecht, Susanne ^a   Mahlknecht, Ulrich ^a   Letzel, Stephan ^a   Fierlbeck, Gerhard ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON;

AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MELANOMA; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; SKIN TUMOR; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTERFERON-BETA; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 39049191935     PISSN: 15409740     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-9740.2006.05678.x     Document Type: Article

References (0)